Related Experiment Video
Updated: Feb 9, 2026

Breath Collection from Children for Disease Biomarker Discovery
Published on: February 14, 2019
[Justification of off-label antibiotics uses in hospitalized children]
Christelle Berthod1, Behrouz Kassaï2, Remy Boussageon3
1Centre d'investigation clinique pédiatrique CIC 1407 Inserm-UMR 5558 CNRS Lyon, université et hospices civils de Lyon, 69003 Lyon, France.
Insights
Unlicensed and off-label antibiotic use in children lacks strong evidence from randomized controlled trials (RCTs). While licensed antibiotics showed more evidence than off-label ones, no prescriptions met high-quality study standards.
Area of Science:
- Pediatric Pharmacology
- Evidence-Based Medicine
- Drug Utilization Studies
Background:
- Unlicensed and off-label (UL/OL) drug use, particularly antibiotics, is common in pediatric care.
- The justification for this practice, especially concerning the quality of supporting evidence, remains unclear.
Purpose of the Study:
- To compare the level of evidence supporting UL/OL antibiotic prescriptions in hospitalized children.
- To determine if UL/OL antibiotic use is supported by high-quality randomized controlled trials (RCTs).
Main Methods:
- An observational study analyzed antibiotic prescriptions in a pediatric hospital.
- Prescriptions were categorized by license status (licensed, UL/OL) and level of evidence (sufficient, insufficient, no evidence).
- The presence of RCTs was assessed for each antibiotic course.
Main Results:
- Of 108 identified antibiotic courses, 34% were off-label; none were unlicensed.
- No proof of efficacy was found for 76 analyzed courses.
- RCTs supported 47% of courses, with licensed antibiotics significantly more likely to be supported (63%) than off-label (16%).
Conclusions:
- High-quality RCTs are largely absent for justifying antibiotic prescriptions in pediatrics, irrespective of license status.
- Licensed antibiotic prescriptions demonstrated more evidence of efficacy compared to off-label ones.
- Further clinical trials are needed to meet pediatric patient needs for evidence-based antibiotic therapy.
Abstract:
Unlicensed and off-label (UL/OL) drugs are commonly used in pediatrics wards, especially the antibiotics. It remains unclear if this strategy is justified by randomized controlled trials of good quality?
Objective:
The aim of this study was to compare the level of evidence of UL/OL antibiotics prescription in hospitalized children. The initial hypothesis was that the UL/OL antibiotics prescriptions had a lower level of evidence than licensed antibiotics.
Method:
This observational study assessed the antibiotics prescription in the children mother and women hospital of Lyon. Each antibiotic medicine courses was classified depending on: (i) they were licensed, UL or OL, (ii) their level of evidence for efficiency (sufficient evidence, insufficient evidence, no evidence) and (iii) the existence or not of randomized controlled trials (RCT) or not. The antibiotics medicine courses in atypical cases were excluded (rare disease, lack of diagnosis, comorbidities modifying antibiotic use). Data were collected with computerized patient file data. The data were compared using Fisher exact test and χ2.
Results:
One hundred and eight medicine courses were identified, corresponding to 72 mono, bi or tri-antibiotic therapies administered to 62 patients; 34% were OL and 66% were licensed. No prescriptions were UL. Thirty-two prescriptions were excluded from the evidence assessment. No proof of efficiency was found for any of the 76 analyzed medicine courses. RCTs were found for 36 of the analyzed medicine courses (47%); licensed medicine courses were significantly more justified by RCTs than UL/OL medicine courses (63% vs. 16%, P<0.001).
Discussion:
This study has shown the absence of RCTs of good quality to justify the prescriptions of antibiotics in pediatrics, regardless their license status. Nevertheless, the licensed prescriptions have shown more data of efficiency than OL prescriptions. Still, even when data were found, no antibiotics prescriptions reach the threshold of good quality studies. New clinical trials should respond to the patient needs.
Related Concept Videos
Drug Dosing: Infants and Children
Development of Antibiotic Resistance
Hospitals-II
Nurses that work in...
Hospitals-I
Antibiotic Selection
Labeling Emotion

